These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4153222)

  • 1. [Lymphocyte-macrophage interaction in the rejection reaction against isologous and homologous ascites tumors (author's transl)].
    Bellelli L; Nista A; Russo M; Sezzi ML
    Tumori; 1974; 60(2):105-22. PubMed ID: 4153222
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
    Zembala M; Ptak W; Hanczakowska M
    Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor effect of lymphocyte and macrophage from mice immunized with Ehrlich ascites tumor cells.
    Sakashita T
    Mie Med J; 1971 Jan; 20(3):227-41. PubMed ID: 5558109
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular and humoral immunity after allogeneic transplantation in the rat. II. Comparison of a 51Cr release assay and modified microcytotoxicity assay for detection of cellular immunity and blocking serum factors.
    Biesecker JL; Fitch FW; Rowley DA; Scollard D; Stuart FP
    Transplantation; 1973 Nov; 16(5):421-31. PubMed ID: 4584952
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity.
    Berke G; Amos DB
    Transplant Rev; 1973; 17(0):71-107. PubMed ID: 4152005
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement phenomenon.
    Petrányi GG
    Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
    [No Abstract]   [Full Text] [Related]  

  • 9. [Participation of soluble H-2 antigens in serological and cellular reactions].
    Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunology of cancer: basic experiments and clinical progress (author's transl)].
    Pasternak G
    Arch Geschwulstforsch; 1973; 42(4):345-57. PubMed ID: 4138903
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of murine C-type viruses. IV. The virus produced by Ehrlich tumor cells and it hybrids with mouse L cells.
    Grundner G; Fenyö EM; Klein E
    Int J Cancer; 1974 Mar; 13(3):420-27. PubMed ID: 4362614
    [No Abstract]   [Full Text] [Related]  

  • 13. T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.
    Wagner H; Röllinghoff M; Nossal GJ
    Transplant Rev; 1973; 17(0):3-36. PubMed ID: 4151904
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro depression of cellular immunity by Friend virus leukemic spleen cells.
    Toy ST; Whellock EF
    Cell Immunol; 1975 May; 17(1):57-73. PubMed ID: 1168547
    [No Abstract]   [Full Text] [Related]  

  • 15. The transplantation of bone marrow.
    Jacobs P
    Cent Afr J Med; 1978 Sep; 24(9 Suppl):33-42. PubMed ID: 31240
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of macrophages in tumour immunity.
    Alexander P
    J Clin Pathol Suppl (R Coll Pathol); 1974; 7():77-82. PubMed ID: 4151535
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: studies on cell-mediated immunity and humoral antibody response.
    Mantovani A; Spreafico F
    Eur J Cancer (1965); 1975 Aug; 11(8):537-44. PubMed ID: 1222761
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro approaches to the mechanism of cell-mediated immune reactions.
    Bloom BR
    Adv Immunol; 1971; 13():101-208. PubMed ID: 4947653
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of activated macrophages in nonspecific resistance to neoplasia.
    Hibbs JB
    J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrophage arming factor release by allografted mouse lymphocytes stimulated by phytohermgglutinin.
    Caraux J; Dimitriu A; Dy M; Mellor J; Hamburger J
    Transplantation; 1975 May; 19(5):369-72. PubMed ID: 1154486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.